DRUG
Bright Minds Biosciences Inc
48.30$
-3.1%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.1% | -5.2% | -3.9% | -2.8% | +856.6% | -3.3% | -7.0% | +60.8% | +7.7% | +243.5% | -0.4% | |
| – | +0.4% | -4.9% | -3.6% | -4.5% | +872.5% | -3.3% | -7.0% | +61.0% | +7.7% | +243.7% | -0.4% | |
| – | +0.2% | -12.3% | +4.3% | -7.6% | +912.2% | -3.8% | -7.7% | +61.3% | +7.4% | +247.3% | -0.4% | |
| – | +0.2% | -12.3% | +4.3% | -7.6% | +912.2% | -3.8% | -7.7% | +61.3% | +7.4% | +247.5% | -0.4% | |
| – | +21.8% | +1,128.4% | -96.9% | +191.4% | +33.4% | +248.5% | +16.7% | +51.5% | +21.7% | +126.6% | -3.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +204.1% | -1.0% | -78.9% | +218.1% | +0.6% | +27.2% | -8.1% | +255.9% | -32.7% | +139.5% | -33.5% | |
| – | +204.1% | -1.0% | -78.9% | +196.0% | -12.7% | +38.2% | -5.2% | +286.0% | -32.2% | +142.0% | -33.5% | |
| – | -25.8% | -36.3% | -59.6% | +466.4% | -8.5% | +7.0% | +0.6% | +8.1% | +4.3% | -6.8% | -20.1% | |
| – | +338.6% | +0.2% | -81.3% | +172.4% | -8.3% | +47.5% | -7.3% | +234.8% | -16.3% | +153.6% | -34.9% | |
| – | -8.6% | -5.8% | +7.3% | -9.2% | +944.5% | -3.6% | -7.0% | +58.3% | +8.8% | +245.3% | 0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.9% | +16.2% | +4.1% | +0.0% | +0.0% | +0.0% | +52.4% | +1.2% | +8.3% | +23.6% | +2.5% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.